Suppressor of cytokine signaling 1 inhibits cytokine induction of CD40 expression in macrophages

Journal of Immunology

Volumn 169, Issue 5, 2002, Pages 2354-2360

  Wesemann, Duane R ^a   Dong, Yuanshu ^a   O'Keefe, George M ^a   Nguyen, Vince T ^a   Benveniste, Etty N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MESSENGER RNA; STAT1 PROTEIN; STAT1ALPHA PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; AUTOCRINE EFFECT; CYTOKINE PRODUCTION; CYTOKINE RELEASE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 0036721604     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.5.2354     Document Type: Article

References (57)

1. The CD40/CD154 receptor/ligand dyad
2. The X-linked hyperimmunoglobulin M syndrome
3. CD40 engagement stimulates IL-12 p70 production by human microglial cells: Basis for Th1 polarization in the CNS
4. 2 secretion by microglia during antigen presentation to Th1 cells
5. Inhibition of CD40 signaling pathway by tyrphostin A1 reduces secretion of IL-12 in macrophage, Th1 cell development and experimental allergic encephalomyelitis in SJL/J mice
6. CD40 and CD154 in cell-mediated immunity
7. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice
8. CD40 signaling and Alzheimer's disease pathogenesis
9. Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases
10. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis
11. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis
12. CD40-CD40L interactions in atherosclerosis
13. Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury
14. Induction of CD40 on human endothelial cells by Alzheimer's β-amyloid peptides
15. Alzheimer's β-amyloid peptides induce inflammatory cascade in human vascular cells: The roles of cytokines and CD40
16. CD40-CD40L interactions induce chemokine expression by human microglia
17. CD40L blockade prevents autoimmune encephalomyelitis and hampers Th1 but not Th2 pathway of T cell differentiation
18. Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses
19. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis
20. Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis
21. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease
22. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation
23. Reduction of atherosclerosis in mice by inhibition of CD40 signalling
24. Post-transcriptional inhibition of CD40 gene expression in microglia by transforming growth factor-β
25. Involvement of STAT-1α and ets family members in interferon-γ induction of CD40 transcription in macrophages/microglia
26. Critical role of TNF-α and NF-κB in IFN-γ-induced CD40 expression in microglia/macrophages
27. A family of cytokine-inducible inhibitors of signalling
28. A new protein containing an SH2 domain that inhibits JAK kinases
29. Structure and function of a new STAT-induced STAT inhibitor
30. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop
31. The elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families
32. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation
33. Socs1 binds to multiple signalling proteins and suppresses Steel factor-dependent proliferation
34. SOCS-1/JAB/SSI-1 can bind to and suppress tec protein-tyrosine kinase
35. Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor α-induced cell death in fibroblasts
36. SOCS-1 is a potent inhibitor of IL-4 signal transduction
37. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1
38. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice
39. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality
40. SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine
41. Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1)
42. IFN-γ regulation of class II transactivator promoter IV in macrophages and microglia: Involvement of the suppressors of cytokine signaling-1 protein
43. Induction of Jak/STAT signaling by activation of the type I TNF receptor
44. Stat 1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-κB activation
45. Defective TNF-α-induced apoptosis in STAT-null cells due to low constitutive levels of caspases
46. Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both β interferon- and interferon-stimulated genes but is not a primary transcriptional activator of either
47. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex
48. CD40-CD40 ligand interaction in autoimmune disease
49. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity
50. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system
51. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes
52. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production
53. Tumor necrosis factors-α and -β bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-κB at low receptor occupancy and within minutes after receptor binding
54. RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis
55. Regulation of CD40 function by its isoforms generated through alternative splicing
56. CD40 and its crucial role as a member of the TNFR family
57. IL-4-activated STAT-6 inhibits IFN-γ-induced CD40 gene expression in macrophages/microglia